INTRODUCTION
In all eukaryotic cells studied thus far, AMP deaminase (EC 3.5.4.6) catalyses the essentially irreversible aminohydrolysis of 5'-AMP to equimolar amounts of 5'-IMP and ammonia [1] .
Mammalian AMP deaminase from skeletal muscle has been extensively investigated, largely as a result of its very high activity in this tissue [2] and the inherited AMP deaminase deficiency syndrome in humans [3] . Deamination of AMP is the first step in the purine nucleotide cycle, making AMP deaminase a key enzyme for adenylate salvage in working skeletal muscle [4] .
In heart muscle (myocardium), AMP deaminase may contribute to the purine nucleotide and nucleoside catabolism associated with myocardial ischaemia [5] . Accelerated AMP flux through this enzyme in the ischaemic heart has been reported to increase myocardial IMP levels and compete with cytosolic 5'-nucleotidase (5'-ribonucleotide phosphohydrolase, EC 3.1.3.5) for available AMP [6] . Heart muscle-cell IMP production is activated by az-adrenergic stimulation [7] , suggesting that cardiac AMP deaminase is under highly complex regulation in situ. Furthermore, cardiac AMP deaminase may be an isoenzyme distinct from the routinely studied skeletal-muscle enzyme [2] . These considerations argue for direct study of AMP deaminase from mammalian heart.
The methods devised for isolation of mammalian AMP deaminase have focused almost exclusively on skeletal muscle [2, 8, 9] . Direct characterization of mammalian cardiac AMP deaminase is lacking for want of a homogenous enzyme preparation. We describe here our work which has afforded purified was a tetramer. Cardiac AMP deaminase displayed a sigmoidal substrate-saturation curve in the presence of 100 mM KCI. Apparent Michaelis constants were a Km of 5.8 mM AMP and a Vmax. of 11.1 utmol/min per mg of protein. ATP and ADP were positive allosteric effectors of cardiac AMP deaminase: the apparent Km was decreased to 1.7 mM by 1.0 mM ATP. The enzyme was inhibited by GTP, coformycin, coformycin 5'-phosphate, palmitoyl-CoA, inorganic phosphate compounds, and the metal chelator o-phenanthroline. No inhibition either by product nucleotide (IMP) or by nicotinamide nucleotides was detected when these agents were examined at concentrations up to 2.5 mM. We conclude that this enzyme preparation offers a means by which the kinetic mechanism and regulation of mammalian cardiac AMP deaminase may be directly investigated.
The left-ventricular myocardium was rapidly dissected away and extensively rinsed with buffer A [54 mM KH2PO4, 35 mM K2HPO4, 0.1 % (v/v) ,b-mercaptoethanol, pH 6.5] containing 0.18 M KCl. The myocardial tissue was blotted, weighed, and added to buffer A containing 0.18 M KCI to form a 10 % (w/v) tissue suspension when homogenized in a precooled Waring blender set at maximum speed; four 1 min homogenizations were conducted. The resulting homogenate was filtered through 4-ply cheesecloth, and the filtrate was centrifuged for 10 min at 121 g. The supernatant was recovered and centrifuged for 30 min at 17 500 g. (NH4)2SO4 was slowly added to the resulting supernatant (cytosolic fraction) to give 20% saturation, and the mixture was centrifuged for 30 min at 17500 g. The pellet was discarded, additional (NH4)2SO4 was added to the supernatant to give 60 % saturation, and this solution was centrifuged for 30 min at 17 500 g. The resulting pellet was resupended in 100 ml of buffer A containing 1 M KCI and was extensively dialysed against 2 litres of buffer A containing 0.1 M KCl. The dialysed extract was centrifuged for 15 min at 27500 g, and the clear supernatant was added to cellulose phosphate (10 ml of supernatant/g of cellulose phosphate) which had been preactivated by successive washings with: 0.5 M NaOH for 5 min; distilled water for 15 min; 0.5 M HCI for 5 min; distilled water for 15 min; 10-times-concentrated buffer A containing 0.18 M KCI for 5 min; and finally, buffer A containing 0.18 M KCl. The slurry was stirred for 6 h and centrifuged for 5 min at 750 g. The pellet was washed three times with buffer A, and the bound AMP deaminase was extracted by three washes (100 ml total volume) with buffer A containing 1.0 M KC1. The extract was dialysed against buffer A containing 0.18 M KCI, and the retentate was concentrated by ultrafiltration with a PM-30 membrane (Amicon, Danvers, MA, U.S.A.). The concentrated extract was applied to a Sephacryl S-300 column (100 cm x 26 mm; V.
-90 ml) which had been pre-equilibrated with buffer A. The column was eluted with 500 ml of buffer A, and 3.5 ml eluate fractions were collected and assayed for AMP deaminase activity. The active fractions were pooled, concentrated to 10 ml, and applied to an AMP-Sepharose column (8.0 cm x 1.5 cm) which had been preequilibrated with buffer A. The column was washed with 20 ml of buffer A, and the enzyme was eluted with a linear gradient of 0-1.0 M KCI in buffer A; 2.0 ml fractions were collected and assayed for AMP deaminase activity. The peak active fractions (-0.4-0.5 M KCI) were pooled and concentrated by ultrafiltration to -0.2 mg of protein/ml. The concentrate was made 10% (v/v) in glycerol and stored at 4°C for no more than
Gel electrophoresis and h.p.l.c. SDS/PAGE was performed as described by Laemmli [11] , in 10 % (w/v) polyacrylamide slab gels. The pre-stained lowmolecular-mass protein markers were: phosphorylase b (106 kDa), BSA (80 kDa), ovalbumin (49.5 kDa), carbonic anhydrase (32.5 kDa), soybean trypsin inhibitor (27.5 [12] . Adenosine deaminase (adenosine aminohydrolase, EC 3.5.4.4) was assayed in 54 mM potassium phosphate buffer (pH 7.4) containing 500 ,M adenosine [13] and quantified by microchemical ammonia determination [12] . 5'-Nucleotidase activity was assayed radiometrically [14] . For The system was fitted with a Radial-pak silica pre-column aration and identification [I 5-17].
Protein assay Protein was quantified with BSA as the standard [18] . Protein in eluates from chromatographic columns used during AMP deaminase isolation was monitored at 280 nm with an on-line spectrophotometric detector.
RESULTS

Purffication of cardiac AMP deaminase
The activity profile for a typical AMP deaminase isolation from rabbit left-ventricular heart muscle is given in Table 1 . All of the cardiac AMP deaminase activity was soluble and associated with the cytosol fraction (i.e. the 17 500g supernatant derived from the (Figure 1 ). Consequently, the cellulose phosphate fraction was subjected to gelpermeation chromatography on Sephacryl S-300 such that the AMP deaminase specific activity increased over 4-fold (Table 1) and the polypeptide heterogeneity of the cellulose phosphate fraction was markedly diminished (Figure 1 ). The material recovered from the gel-permeation column was subjected to affinity chromatography on AMP-Sepharose. Elution of the AMP-Sepharose column with buffer A containing 1.0 M KCl significantly decreased the heterogeneity of the loaded Sephacryl S-300 fraction, for the AMP-Sepharose eluate contained a single major polypeptide band of apparent molecular mass 81 kDa (Figure 1 ). However, a second polypeptide with apparent molecular mass 73kDa was also detected (Figure 1 ). Re-chromatography of such preparations on AMP-Sepharose did not remove this 73 kDa peptide completely, and inclusion of protease inhibitors (leupeptins, pepstatin A and phenylmethanesulphonyl fluoride) at micromolar levels throughout the isolation procedure described did not prevent its appearance. Densitometric scans of stained SDS/PAGE gels (e.g. Figure 1 , lane 5) demonstrated that the 73 kDa peptide was a minor component which constituted < 5 % of the total fraction protein.
The lack of electrophoretic homogeneity of the above AMPSepharose fraction led us to elute the AMP-Sepharose column first with KCl-free buffer and then with a linear KCl gradient. This procedure yielded two discrete protein peaks from the Sephacryl S-300 fraction, one of which was eluted with 0 M KCI and contained negligible AMP deaminase activity (Figure 2) . A linear 0-1.0 M KCl gradient was then established, within which (Figure 1) . The experimentally determined specific activity of AMP deaminase across the peak AMP-Sepharose fractions after gradient elution was 6.5 + 0.5,umol/min per mg of protein at saturating substrate concentration. This affinity-purified fraction represented some 19 % of the total cardiac AMP deaminase activity and -0.16 % of total tissue protein ( Table 1 ).
Molecular properties
In the studies described below, electrophoretically homogeneous AMP deaminase preparations were used which, by SDS/PAGE, consisted of the 81 kDa component under conditions of loading whereby minor species ( < 1 % of total) would have been stained and detected. Gel-filtration h.p.l.c. ofthe cardiac AMP deaminase preparation under non-denaturing conditions resolved a single symmetrical protein peak at an elution volume which corresponded to an apparent molecular mass of 330 kDa. A denatured enzyme sample run on size-exclusion h.p.l.c. evidenced a single peak with apparent molecular mass 80 kDa. The sizeexclusion h.p.l.c. profile and the apparent-molecular-mass data from SDS/PAGE indicated that the cardiac AMP deaminase preparation contained a discrete tetrameric protein. Partial amino acid analysis identified a single unique N-terminal residue, leucine, in our AMP deaminase preparation.
Stability
Isolated cardiac AMP deaminase was routinely stored at a concentration of -0.2 mg of protein/ml in buffer A containing 50 mM KCI and 10% (v/v) glycerol at 4 'C. Under these conditions, there was an -20 % loss of activity over a 2-week period. No increase in activity with storage was observed.
Dithiothreitol () 1OO,uM final concn.) and/or protease inhibitors did not alter the stability profile. Cardiac AMP deaminase activity was lost with freeze-thawing in the above storage solution.
pi
The pl of isolated rabbit heart AMP deaminase was 6.5 as determined in a Rotofor isoelectric-focusing cell. Thus the enzyme in aqueous solution at physiological pH bears a net negative charge. Kinetic properties Rabbit heart AMP deaminase was markedly stimulated by cations (Figure 3 ). Mg2+ and Ca2+ activated the enzyme in the low-millimolar range. At higher millimolar concentrations, K+ was the most effective univalent-cation activator. In the presence of 100 mM KCI, full activity was reached, and cardiac AMP deaminase displayed a sigmoidal response to increasing substrate concentration ( Figure 4) . Transformation of the substratesaturation data by the Lineweaver-Burk method [19] yielded a linear double-reciprocal plot ( Figure 4) Figure 4 . The metal chelator o-phenanthroline inhibited the enzyme in the sub-millimolar range, whereas millimolar concentrations of inorganic (poly)phosphates were necessary for inhibition ( Figure 5 ). Micromolar concentrations of coformycin, a transition-state inhibitor of adenosine deaminase [20] , inhibited cardiac AMP deaminase in the presence of 5 mM AMP ( Figure  5 ). The 5'-monophosphate analogue of coformycin [10] was inhibitory at nanomolar concentrations ( Figure 5 ). PalmitoylCoA virtually abolished cardiac AMP deaminase activity at 10 luM, whereas palmitic acid and short-chain CoAs (acetyl, butyryl) were inactive ( Figure 5 , and results not shown). EHNA, a specific adenosine deaminase inhibitor [21] , did not affect cardiac AMP deaminase at concentrations up to 10,M. The the peak activity remained.
putative AMP deaminase inhibitor AICA ribotide [22] was without effect at millimolar concentrations. Inhibition of rabbit cardiac AMP deaminase by product nucleotide (IMP) was not observed up to 2.5 mM IMP concentration. Likewise, no inhibition (or stimulation) by nicotinamide nucleotides was detected at a concentration of 2.5 mM.
DISCUSSION
The present work constitutes the first study of purified AMP deaminase from mammalian myocardium. The protocol of Smiley et al. [9] for skeletal-muscle AMP deaminase isolation via cellulose phosphate cation-exchange chromatography has been almost universally employed to generate 'enriched' AMP deaminase preparations from avian [23] , rat [24] , bovine [25] , pig [26] , human [27] and rabbit [28] [29] [30] heart tissue. Molecular characterization of the AMP deaminase activity in such cardiac preparations has not been reported. There is some doubt as to whether the method of Smiley et al. [9] yields a homogeneous AMP deaminase preparation even from skeletal muscle [8] . As our work conclusively demonstrates (Table 1 and Figure 1 ), cation-exchange chromatography alone is insufficient to generate even a near-homogeneous cardiac AMP deaminase preparation. Two elaborations of the Smiley et al. [9] procedure for heart tissue employed either anion-exchange column chromatography [25] [32] . Variable molecular masses from 238 kDa to 326 kDa have been reported for skeletal-muscle AMP deaminase within and across species [33] . The only study other than the present one to specify a molecular mass for cardiac AMP deaminase reported that the bovine heart enzyme was a 160 kDa protein [25] . The literature range of molecular masses probably reflects a proteolytic artifact, for data on human and rat skeletal-muscle AMP deaminase genes allow extrapolation that the holoenzyme molecular mass is at least 320 kDa [34] .
The kinetic properties of purified rabbit heart AMP deaminase differ markedly from those of the skeletal-muscle enzyme. Although both require millimolar K+ for full activity, the former is more readily activated by bivalent cations than the latter [9] . The apparent Km of 5.8 mM AMP for rabbit cardiac AMP deaminase is greater than the Km of 0.3-0.7 mM generally reported for (rabbit) skeletal-muscle AMP deaminase [29, 35] The activity of isolated rabbit heart AMP deaminase was modulated by several effectors: ADP, ATP, GTP, inorganic (poly)phosphate compounds and fatty acyl-CoAs. Allosteric activation by ADP and ATP and inhibition by GTP, phosphates and fatty acyl-CoA have been observed in enriched cardiac AMP deaminase preparations [23, 24, 27, 28] and with the isolated skeletal-muscle enzyme [37, 38] . Quantitatively, however, variable sensitivities toward each effector have been reported. For example, we demonstrate that the Km of purified rabbit heart AMP deaminase was decreased 3.4-fold by 1.0 mM ATP, whereas a 7-fold decrease was reported for a crude preparation of this enzyme [29] . Non-homogeneous cardiac AMP deaminase exhibited greater sensitivity to millimolar ADP than ATP [28] , whereas the isolated rabbit heart enzyme was somewhat more sensitive to ATP (Figure 4) . At least some of these discrepancies may reflect contamination ofcrude AMP deaminase preparations by nucleoside-diphosphate kinase (ATP: nucleoside-diphosphate phosphotransferase, EC 2.7.4.6) and/or adenylate kinase (ATP: AMP phosphotransferase, EC 2.7.4.3.).
Purified rabbit heart AMP deaminase was not affected by 2.5 mM nicotinamide nucleotides or IMP, whereas an enriched preparation from rat heart was inhibited by over 90 % by 1.0 mM NADI and stimulated slightly by 1.0 mM NADP+ [31] . Conflicting data exist concerning the effect of IMP on skeletalmuscle AMP deaminase: 0.5 mM IMP activated rabbit muscle AMP deaminase [39] , yet 1.0 mM IMP inhibited the chick muscle enzyme [40] . Given that 2.5 mM IMP did not inhibit purified rabbit heart AMP deaminase, the cardiac enzyme appears markedly insensitive to product inhibition.
The present work provides the first demonstration of cardiac AMP deaminase inhibition by o-phenanthroline, coformycin and coformycin 5'-monophosphate. Inhibition of skeletal-muscle AMP deaminase by o-phenanthroline reflects a requirement for bound zinc for catalysis [41] ; cardiac AMP deaminase likewise appears to be a zinc metalloprotein. As with skeletal-muscle AMP deaminase [40] , the purified cardiac enzyme was inhibited to a much greater degree by the 5'-monophosphate derivative of coformycin than by coformycin itself. These compounds are known transition-state inhibitors of AMP deaminase and, with respect to coformycin, of adenosine deaminase as well [20] . However, the potent adenosine deaminase inhibitor EHNA did not inhibit isolated cardiac AMP deaminase, in line with results reported for the rabbit skeletal-muscle enzyme [42] . We were unable to demonstrate inhibition of rabbit heart AMP deaminase by AICA ribotide at concentrations which purportedly inhibited skeletal-muscle AMP deaminase [22] . As discussed elsewhere [43] , interference by AICA ribotide in the u.v.-spectrophotometric assay for AMP deamination may have complicated the results of Baggott et al. [22] . We did not detect multiple molecular forms ofAMP deaminase in rabbit heart through gradient elution at either the cationexchange (i.e. cellulose phosphate) (cf. [25] ) or the AMPSepharose (Figure 2) step. This finding is reminiscent of data from Ogasawara et al. showing that soluble extracts from rat [1] and rabbit [30] hearts contained a single activity peak on cellulose phosphate. In contrast, one major (-85 % of total activity) and two minor activity peaks were identified in rat heart [31] , and two apparent peaks of bovine heart AMP deaminase activity were eluted from cellulose phosphate [25] . Three distinct AMP deaminase activity peaks have been resolved through cellulose phosphate chromatography of a human heart extract [2] . These data suggest that species-specific cardiac AMP deaminase isoforms may exist. Further experimental work is required to address this point and to define the physiology of AMP deaminase in normal and diseased myocardium.
